Companies / 1AD

ADALTA LIMITED

ASX:1ADPharmaceuticals, Biotechnology & Life Sciences
3.21B shares on issueASX (delayed) · as of 28 July 2026$0.004price · delayed$11.2Mmarket cap · indicative
F
Dilution grade

Runway under 2 quarters; share count grew 433% in 24 months; 12 cash raises in 24 months

Cash runway0.3 quarters of funding
Share-count growth (24m)433.0%
Raise cadence (24m)12 cash raises
Options & rights overhang39.2% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

ADALTA LIMITED's ordinary share count grew 433.0% between June 2024 and July 2026, to 3.17B shares. The company raised capital 12 times in that period for total disclosed proceeds of A$16.8M, most recently a A$2.5M placement in May 2026. Options and rights on issue could convert into 1.26B new shares, equal to 39.2% of the current share count, with 0% in the money at the current share price and the nearest expiry in June 2028. At the March 2026 quarter the company reported A$580K in available cash, about 0.3 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
39.2%
Max option dilution
0.0%
ITM option dilution
7
Raises · last 12 months
0.3 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 3.21B per ASX (delayed) (28 July 2026).
1.17B1.92B2.67BDec 24Sept 25July 26Cash raise · 25 May 2026Cash raise · 29 Apr 2026Cash raise · 13 Jan 2026Cash raise · 12 Jan 2026Cash raise · 27 Oct 2025Cash raise · 20 Oct 2025Cash raise · 10 Oct 2025Cash raise · 11 July 2025Cash raise · 2 June 2025Cash raise · 29 Apr 2025Cash raise · 17 Mar 2025

Cash runway

0.3 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$580k available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
1 July 20262A · quoted issue1AD : ORDINARY FULLY PAID3.17BAppendix 2A
1 July 20262A · quoted issue1AD : ORDINARY FULLY PAID3.01BAppendix 2A
25 June 20262A · quoted issue1AD : ORDINARY FULLY PAID2.98BAppendix 2A
17 May 20262A · quoted issue1AD : ORDINARY FULLY PAID2.66BAppendix 2A
2 Apr 20263H · cancellation1AD : ORDINARY FULLY PAID2.55BAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

12 cash raises in the last 24 months · 7 in the last 12 months

$2.5M
Placement
25 May 2026 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

39.2%
Total overhang · of current shares
0.0%
In the money · at current price
1.26B
Potential new shares
June 2028
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
29 Nov 2025Tim OldhamSell1.4M1.2M—3Y notice
29 Nov 2025David FullerSell—1.2M—3Y notice
29 Nov 2025Paul MacLemanSell—3.1M—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

19 July 2026ISCTANZ2026 presentation and poster
13 July 2026ISCT poster awarded oral presentation
1 July 2026Cleansing Notice
1 July 2026Application for quotation of securities - 1AD
1 July 2026Application for quotation of securities - 1AD
1 July 2026$POktopi AI collaboration for research efficiency
30 June 2026$PSecond BZDS1901 milestone paid
25 June 2026Cleansing Notice
25 June 2026Application for quotation of securities - 1AD
15 June 2026Results of Meeting
8 June 2026Confirmation of results of Prospectus Offer
24 May 2026Proposed issue of securities - 1AD
24 May 2026Target Market Determination
24 May 2026$PProspectus
24 May 2026$PRegulatory advisors appointed for BZDS1901
17 May 2026Cleansing Notice
17 May 2026Application for quotation of securities - 1AD
14 May 2026Notice of EGM & Proxy Form
11 May 2026Webinar presentation - new hope for mesothelioma patients
6 May 2026Investor webinar - new hope for mesothelioma patients

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.